The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.

Gaujoux-Viala C, Tropé S, Buisson A, Lacombe F, Bocquet F, Languérand E, Cordurié L, Margulies G, Le Berre C, Vittecoq O.

Open source

DOI
10.2147/jmdh.s528370
Published
2025-10-14
Container
J Multidiscip Healthc
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jmdh.s528370,
  title = {The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.},
  author = {Gaujoux-Viala C and  Tropé S and  Buisson A and  Lacombe F and  Bocquet F and  Languérand E and  Cordurié L and  Margulies G and  Le Berre C and  Vittecoq O.},
  year = {2025},
  journal = {J Multidiscip Healthc},
  doi = {10.2147/jmdh.s528370},
  url = {https://doi.org/10.2147/jmdh.s528370}
}

RIS

TY  - JOUR
TI  - The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.
AU  - Gaujoux-Viala C
AU  -  Tropé S
AU  -  Buisson A
AU  -  Lacombe F
AU  -  Bocquet F
AU  -  Languérand E
AU  -  Cordurié L
AU  -  Margulies G
AU  -  Le Berre C
AU  -  Vittecoq O.
PY  - 2025
JO  - J Multidiscip Healthc
DO  - 10.2147/jmdh.s528370
UR  - https://doi.org/10.2147/jmdh.s528370
ER  - 

APA

C, G., S, T., A, B., F, L., F, B., E, L., L, C., G, M., C, L. B., & O., V. (2025). The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.. J Multidiscip Healthc. https://doi.org/10.2147/jmdh.s528370

Source records